Cyto Pulse Sciences , Inc.

Industry:	Medical Devices & Equipment
Revenues:	$870,000
Employees:	10

Description

Cyto Pulse was founded in December 1995 and is incorporated as a regular C corporation in Maryland. The company is composed of a multidisciplinary staff of engineers and scientists. Cyto Pulse develops electric field based devices for use in vaccine delivery, vaccine production, personal vaccine production, gene therapy, and hybridoma production.

In recent years, there have been great advances in immunotherapy and gene therapy against such difficult targets as metastatic cancer, genetic defects, and acute viral infections. In many cases these advances have relied on the use of DNA and RNA. Today there are still no approved clinical uses of this technology because of the inability to deliver, safely and effectively, the DNA/RNA into the target cells. Cyto Pulse, a medical device company, has solved this problem with proprietary technologies using non-viral electric fields. After extensive preclinical studies these are now entering several human trials. The principal Cyto Pulse applications are the production of DNA therapeutic vaccines, delivery of DNA vaccines, modification of cell genomes to correct genetic defects, production of hybridoma vaccines by fusing immune system cells and tumor cells, and the production of hybridomas used to produce monoclonal antibodies. The annual markets for these treatments and vaccines are expected to be in the billions of dollars per year. The Cyto Pulse expertise and intellectual property is in waveform generators and electrodes for use in immunology and viral target vaccine applications.

Products & Services

medical device

News Archive

Companies Chosen to Present at Larta Institute's 15th Annual Life Sciences Venture Forum. Health & Beauty Close-Up; 6/5/2009 ...present at the 2009 Life Sciences Venture Forum include Auritec Pharmaceuticals, Charlesson, Cognosci, CollEngin, Cyto Pulse Sciences, ECI Biotech, Fairway Medical Technologies, Fluential, iVisit, Mind Matters Research, NanoVector, PDS Biotechnology... ...more

Other News To Note. BIOWORLD Today; 11/3/2009 ...up of manufacturing of the product for efficacy and safety studies in patients with acute and chronic pain. o Cyto Pulse Sciences Inc., of Glen Burnie, Md., received a $2 million Phase II grant from the National Institute of Allergy and... ...more

Cyto Pulse, the Karolinska Hospital/Institutet and SMI Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Evaluating a CEA-based Vaccine in Patients with Colorectal Cancer. Cancer Gene Therapy Week; 11/16/2009 Cyto Pulse Sciences, a leading producer of electric...KI) and Cyto Pulse (see also Cyto Pulse Sciences, Inc.). Britta Wahren, M.D...medical training and research. About Cyto Pulse Sciences Cyto Pulse Sciences, Inc. is a... ...more